A DNA fragment of 485 bp was specifically amplified by PCR with primers based on the N-terminal sequence of the purified formaldehyde dehydrogenase (EC 1.2.1.46) from Pseudomonas putida and on that of a cyanogen bromide-derived peptide. With this product as a probe, a gene coding for formaldehyde dehydrogenase (fdhA) in P. putida chromosomal DNA was cloned in Escherichia coli DH5ot. Sequencing analysis revealed that thefdhA gene contained 1,197-bp open reading frame, encoding a protein composed of 399 amino acid residues whose calculated molecular weight was 42,082. The transformant of E. coli DH5ot harboring the hybrid plasmid, pFDHK3DN71, showed about 50-fold-higher formaldehyde dehydrogenase activity than P. putida. The predicted amino acid sequence contained several features characteristic of the zinc-containing medium-chain alcohol dehydrogenase (ADH) family. Most of the glycine residues strictly conserved within the family, including a Gly-Xaa-Gly-Xaa-Xaa-Gly pattern in the coenzyme binding domain, were well conserved in this enzyme. Regions around both the catalytic and the structural zinc atoms were also conserved. Analyses of structural and enzymatic characteristics indicated that P. putida FDH belongs to the medium-chain ADH family, with mixed properties of mammalian class I and III ADHs.
A(IacIZYA-argF)U169 recAl endA41 gyrA96 thi-I supE44 relAl mcrA mcrB+ hsdRl7] and JM105 [F' (traD36 proAB+ lacIqAlacZM15) A(lac-proAB) thi endAl supE sbcB15 rpsL hsdR4] were used as the hosts for cloning. Plasmids pBR322 and pBluescript SK(-) and phagemids M13mpl8 and M13mpl9 were used for cloning. Bacteria were grown in Luria-Bertani broth.
Assay of FDH activity. Activity assays were performed by two different methods.
(i) Fbrmation of diformazan. The reaction mixture (1.2 ml), containing 50 mM Tris-HCl (pH 8.0), 0.2% Triton X-100, 2 mM formaldehyde, 1 mM NAD+, 25 ,uM phenazine methosulfate, 100 ,iM nitroblue tetrazolium, and 0.002 to 0.015 U of enzyme, was incubated for 15 min at 37°C. The reaction was stopped by the addition of 3 ml of 0.3 N HC1, and diformazan formed via the NADH-phenazine methosulfate-nitroblue tetrazolium coupling reaction was spectrophotometrically measured at 570 nm. One unit was defined as the amount of enzyme which formed 0.5 jimol of diformazan per min under the above-described conditions.
(ii) Formation of NADH. For the determination of kinetic parameters, activity was assayed by monitoring the formation of NADH at 340 nm with a reaction mixture of 50 mM glycine-NaOH (pH 8.9), 0.1 to 2 mM formaldehyde, 1 mM NAD+, and 0.005 to 0.01 U of enzyme at 37°C.
Purification of the native enzyme. All purification procedures were carried out at 4°C unless otherwise stated. A commercial preparation of P. putida FDH (TOYOBO) (30 mg) was dissolved in 3 ml of 20 mM K-phosphate buffer (pH 6.8) and passed through a column (1.5 by 68 cm) of Hiload Superdex 200 pg (fast protein liquid chromatography system; Pharmacia) equilibrated with the same buffer at a flow rate of 0.5 mlmin. Three-milliliter fractions were collected. This step was repeated three times. Active fractions were combined and applied to a column (1.4 by 14 cm) of hydroxyapatite equilibrated with the same buffer at a flow rate of 0.15 ml/min. The adsorbed enzyme was eluted by using an increasing linear gradient of 20 to 500 mM K-phosphate buffer (pH 6.8) in a total volume of 300 ml, and 5-ml fractions were collected. Active fractions were combined and dialyzed against distilled water. The final preparation was lyophilized and stored at -200C.
Proteolytic and CNBr cleavages of the purified FDH and amino acid sequence analyses of the peptide fragments derived. For proteolytic cleavage, the purified enzyme (1.2 mg) was digested with 60 ,ug of S. aureus V8 protease in 1 ml of 0.1 M K-phosphate buffer (pH 7.8) for 24 h at 37°C. For cyanogen bromide (CNBr) cleavage, the enzyme (1 mg) was incubated in 1 ml of 70% formic acid solution containing 2.2 mg of CNBr under N2 gas in the dark for 15 h at room temperature, diluted with 3 ml of distilled water, and then lyophilized. Peptide mixtures obtained by enzymatic and CNBr cleavages were subjected to reversed-phase high-pressure liquid chromatography on a Vydac C18 column (particle size, 5 jim; pore diameter, 300 A [30 nm]; 4.6 by 250 mm; Separations), using a solvent system of 0.075% trifluoroacetic acid in water versus acetonitrile-2-propanol (3:1) in 0.06% trifluoroacetic acid. Amino acid sequences of the amino-terminal region of the purified enzyme and of peptides derived from V8 protease and CNBr cleavages were determined by the manual Edman degradation method (23) .
Preparation of DNAs. P. putida chromosomal DNA was prepared by the method of Saito and Miura (31) . Plasmids were isolated by alkali lysis followed by polyethylene glycol 6000 precipitation. Single-stranded DNAs were prepared by a standard protocol (33) 
sisted of 30 cycles of denaturation at 94°C for 1 min, annealing at 50°C for 1 min, and extension at 72°C for 2 min, with a final extension at 72°C for 7 min. Exclusion of dimethyl sulfoxide gave minor, nonspecific amplification products (see Fig. 1 ). The PCR product was fractionated on a 1.2% low-meltingtemperature agarose gel and visualized by ethidium bromide staining. It was purified by phenol extraction and precipitated with ethanol. After being blunted by Klenow fragment, the fragment was subcloned into the SmaI site of M13mpl8 and sequenced by the chain termination method (34) .
Labeling of DNA. DNA fragments were labeled by the method of Feinberg and Vogelstein (11) , using a random primer DNA labeling kit (Takara Shuzo Co.).
Southern hybridization analysis. P. putida chromosomal DNA digested with various restriction enzymes was separated on a 1.0% agarose gel and transferred to a nitrocellulose filter. DNAs on the filter were fixed by heating for 2 h at 80°C. The filter was prehybridized for 2 h at 42°C in a solution containing 50% formamide, 5 x SSC (1 x SSC is 0.15 M NaCl plus 0.015 M sodium citrate), 50 mM Na-phosphate buffer (pH 7.5), 1 X Denhardt's solution, 0.1% sodium dodecyl sulfate (SDS), and 100 jig of denatured salmon testis DNA per ml. Hybridization was carried out in 10 ml of the same solution containing a radiolabeled probe for 16 h at 42°C. After the incubation, the filter was washed twice in 100 ml of 2 x SSC containing 0.1% SDS for 5 min at room temperature and twice in 100 ml of the same solution for 30 min at 60°C and then air dried. The filter was wrapped and exposed to an X-ray film with an intensifying screen at -80°C.
Preparation and screening of a library. P. putida chromosomal DNA was digested with EcoRI and size fractionated on a 1.0% agarose gel. DNA fragments were purified and ligated into the EcoRI site of pBR322 treated with calf intestine alkaline phosphatase. E. coli DH5a was transformed with the ligation mixture and plated on Luria-Bertani plates containing 100 jig of ampicillin per ml. Colonies of the transformants were transferred to nitrocellulose filters and then lysed. The liberated DNA was fixed, and hybridization was carried out as described above.
Subcloning and nucleotide sequence analyses. pBluescript SK( -) (Stratagene) was used for subcloning by standard protocols (33) . The hybrid plasmid pFDHK3, which carried a 2.9-kb insert at the KpnI site of pBluescript SK, was used to construct deletion mutants. pFDHK3 was digested with SacI and EcoRI, and the linearized DNA was deleted from the EcoRI site on the vector by using a Kilosequence deletion kit (Takara Shuzo Co.).
Single-stranded DNAs were prepared from the series of deleted mutants described above by using R408 helper phage according to the manufacturer's instruction. Various restriction fragments were also generated from pFDHK3DN71 by using the restriction sites shown in Fig. 2 15 ,000 x g for 20 min, dissolved in 10 ml of 20 mM K-phosphate buffer (pH 6.8), and dialyzed against the same buffer. FDH was further purified to homogeneity by hydroxyapatite chromatography as described for the purification of the commercial enzyme, except that the gradient was made of 300 ml each of 20 and 500 mM K-phosphate (pH 6.8). Active fractions were combined, and the protein was precipitated by ammonium sulfate at 70% saturation. The precipitate was dissolved in 20 mM Tris-HCl (pH 7.2) and dialyzed against the same buffer. The final preparation was stored frozen in aliquots at -20°C.
Analytical methods. Protein concentrations were determined by the modified Lowry method with bovine serum albumin as a standard (30) . The molecular weight of the enzyme was estimated by gel filtration on a Superdex 200 pg column calibrated with E. coli aminopeptidase P (200 kDa) (42), S. cerevisiae ADH (140 kDa), bovine serum albumin (67 kDa), and Bacillus coagulans proline iminopeptidase (32 kDa) (22) as markers. Gel filtration was carried out as described for the purification of the commercial enzyme, except that 0.5 ml of each sample (0.5 mg) was applied to the column. The elution volume of each protein was determined by measuring the A280. Isoelectric focusing was performed with a commercially available gel (IEF 3-9 gel; Pharmacia), using the Pharmacia PhastSystem apparatus according to the manufacturer's instructions. To determine the isoelectric point, the pI calibration kit from Pharmacia was used as a standard.
Km following treatments. For determination of thermal stability, the purified enzyme (0.1 U) was incubated in 0.1 ml of 100 mM Tris-HCl buffer (pH 8.0) for 30 min at various temperatures (0 to 80°C). For determination of pH stability, the purified enzyme (0.1 U) was incubated in 0.1 ml of various buffers (100 mM) for 30 min at 37°C; the buffers used were Na-acetate buffer (pH 4.0 to 5.5), K-phosphate buffer (pH 6.0 to 7.5), Tris-HCl buffer (pH 7.0 to 8.4), glycine-NaOH buffer (pH 8.4 to 11.5), and Na-bicarbonate-Na-carbonate buffer (pH 9.0 to 10.5).
The DNA and protein sequences were analyzed by using the GENETYX-MAC genetic information processing software (Software Development Co., Ltd., Tokyo, Japan).
Nucleotide sequence accession number. The nucleotide sequence data reported in this paper will appear in the DDBJ, EMBL, and GenBank nucleotide sequence data bases with the accession number D21201.
RESULTS
Determination of partial amino acid sequence of P. putida FDH. To synthesize oligonucleotide primers for PCR, the N-terminal amino acid sequence of the purified enzyme and those of major peptide fragments derived by V8 protease or by CNBr cleavage were determined. As shown below all of these sequences coincided well with those deduced from the nucleotide sequence of the enzyme gene (see Fig. 5 ).
Amplification of FDH gene fragment. Upstream and downstream primers were designed from the N-terminal amino acid sequences of the native enzyme and of a CNBr-derived peptide, B7, respectively. A methionine residue was assumed to occur before the CNBr-derived peptide. Amplification of a P. putida DNA fragment mediated by PCR with primers Ni (upstream) and B7 (downstream) gave a single PCR product of approximately 0.48 kb in length (Fig. 1 ). This PCR product was subcloned into M13mpl9, and its nucleotide sequence was determined. We concluded that the 485-bp fragment was a portion of the FDH gene (fdhA), since amino acid sequences of seven peptide fragments derived from the purified enzyme by proteolytic and CNBr cleavages were found in the amino acid sequence deduced from the nucleotide sequence of this PCR product (see Fig. 5 ).
Screening of P. putida fdhA. P. putida chromosomal DNA was digested with BamHI, EcoRI, HindIII, PstI, and Sall. The enzyme digests were fractionated by 1% agarose gel electrophoresis and transferred to nitrocellulose filters. Hybridization was carried out with the 32P-labeled PCR product as a probe. An EcoRI fragment of 9 kb was found to hybridize to the probe. EcoRI fragments of around 9 kb were extracted from the agarose gel, ligated into the EcoRI site of pBR322, and used to transform E. coli DH5x. The resultant recombinant E. coli library containing P. putida chromosomal DNA fragments was screened by colony hybridization with the same probe. Eight of approximately 1,000 colonies hybridized to the probe. Restriction analysis revealed that all the positive clones had the same 9-kb insert in pBR322 at the EcoRI site. We selected one clone, named El, for further experiments.
Subcloning and expression of fdhA in E. coli. No FDH activity was detected in E. coli DH5ao transformed with El, presumably because of the lack of an active promoter in E. coli within the insert on El. To construct an expression plasmid, a restriction map for El was generated (Fig. 2) . Southern hybridization analysis revealed that the structural gene for FDH existed within the 2.9-kb KpnI fragment. This KpnI fragment was subcloned into pBluescript SK. Two kinds of clones with respect to the orientation of the insert (Ki and K3) were obtained. The recombinant E. coli DH5a harboring K3 showed high-level FDH activity, whereas the one harboring Ki showed no FDH activity, indicating that the transcription of the enzyme gene was dependent on the lac promoter on the vector. To determine the approximate location of the enzyme gene in K3, a series of deleted mutants was constructed, and FDH activities in the respective transformants were measured.
As shown in Fig. 2 , K3 (PstI), which has a PstI-KIpnI fragment of the same orientation as in K3, showed no FDH activity. The 2.9-kb DNA insert in K3 was deleted from the upstream part of the gene. Deletion of 0.8 kb (DN71) increased the activity of the transformant by approximately twofold, but further deletions beyond 1.1 kb (DN105) resulted in loss of FDH activity. Removal of the ApaI-KpnI fragment of the 3' side of the gene from DN71 had little effect on the FDH activity. SDS-polyacrylamide gel electrophoresis (SDS-PAGE) analysis of the total protein contents of the transformants is shown in Fig. 3 . Major bands with an apparent molecular weight of 42,000 were evident, and the amounts of the protein bands seemed to pararell the enzyme activities. These results suggested that the structural gene for FDH was located between the deletion point of DN71 and the Apal site.
Purification and some properties of the expressed enzyme. Table 1 summarizes the purification of the expressed enzyme. The enzyme was purified to near homogeneity as verified by SDS-PAGE (Fig. 4) , with a recovery of 45% of the activity from the cell extracts of E. coli DH5a harboring pFDHK3DN71. The N-terminal amino acid was found to be a serine, indicating that the methionine residue encoded by the initiation codon was similarly removed in both bacteria.
In Table 2 , some properties of the expressed enzyme are compared with those of the native enzyme purified from P. putida. The two enzymes showed almost the same properties. The molecular weight was estimated to be 150,000 by gel filtration, while SDS-PAGE analysis gave a value of 42,000, suggesting that the enzyme exists as a tetrameric form. The isoelectric point calculated from the sequence data was 5 isoelectric focusing for P. putida FDH (2) and with that for the recombinant enzyme.
Both enzymes were active toward formaldehyde and nbutanol but were inactive toward ethanol. External addition of glutathione up to 2 mM did not affect the reaction rate (data not shown). Insensitivity to inhibition with 4-methylpyrazole is a unique characteristic of class III ADH (glutathione-dependent FDH) (41) . Inhibition with this inhibitor was determined in 50 mM glycine-NaOH buffer (pH 8.9). Both enzymes were inhibited by this inhibitor with a Ki value of 30 ,uM, which is in a middle range between the values typically reported for mammalian class I and class II enzymes.
Nucleotide sequence. The nucleotide sequence offdhA, from the deletion point of DN71 to the ApaI site, is shown in Fig. 5 respectively, but no consensus sequences for -35 and -10 regions were found. The GC content of the entire gene was 64%, which agreed with the value for Pseudomonas species (35) . A highly AT-rich region was found around the initiation codon.
Similarity to ADH family. It is well known that zinccontaining ADHs from a wide variety of organisms are structurally related to each other (17) . Recently, the glutathionedependent FDHs from rat and human livers have been identified as class III ADHs. Comparisons were made between the amino acid sequences of P. putida FDH and those of ADH family enzymes from various sources, including horse liver ethanol-active ADH (horse E), the three dimensional structure of which had been solved (10) , in order to clarify structural relationships. The alignment of those sequences is shown in Fig. 6 . This alignment was based on comparisons of the individual sequences with the horse E isozyme structure (1, 3, 17, 18, 26) , with gaps then introduced to maximize the alignment with the primary structure of P. putida FDH. The partial amino acid sequence of E. coli FDH (13) is also shown in Fig.  5 . Two-thirds of the sequence from the N terminus in P. putida FDH showed significant homologies to all of the ADHs compared. J6rnvall et al. indicated that 22 amino acid residues were strictly conserved throughout the family (17) . This number has now been reduced to 14 (1). In P. putida FDH, 18 of 22 residues and 12 of 14 residues, respectively, could be aligned. Most of the glycine residues (10 residues), including a Gly-ADH family. P. putida FDH is significantly longer than other Xaa-Gly-Xaa-Xaa-Gly pattern in the coenzyme binding doenzymes belonging to the medium-chain ADH family because main, and zinc-liganding cysteine (Cys-47) and histidine (His- of the long C-terminal region, which shows little alignment 68) residues were conserved. Besides the active-site zinc, many with any other ADHs. The overall homology of the P. putida medium-chain ADHs contain a structural zinc which is coor-FDH to ADH family enzymes ranged from 14 to 20%. dinated by four cysteine residues. These residues were also
The nucleotide sequence of the P. (29) , human class III ADH (12) , maize ADH2 (6), S. cerevisiae ADHI (4) , Sulfolobus solfataricus ADH (1), Bacillus subtilis sorbitol dehydrogenase (26) , and E. coli threonine dehydrogenase (3), respectively. These values were comparable to or slightly lower than those obtained from comparisons of the ADH structural genes from microbes other than P. putida. DISCUSSION We have cloned the FDH gene (fdhA) from P. putida in E. coli DH5o cells and determined its nucleotide sequence. This is the first report about the sequence of the glutathioneindependent FDH. P. putida FDH was found to be encoded by an open reading frame of 1,197 bp, giving a protein of 399 amino acid residues. The partial amino acid sequences determined by protein sequencing agreed well with those deduced from the nucleotide sequence, except that the mature enzyme lacks methionine encoded by the initiation codon.
The transformant that carried a 2.1-kb fragment inserted into pBluescript showed much greater FDH activity than P. putida. The plasmid pFDHK3DN71 under the control of the lac promoter on the vector could express the enzyme about 50-fold more than P. putida. Amounts of FDH protein could be nearly 30% of the total protein found in cell extracts of E. coli DH5ot harboring pFDHK3DN71, as judged by SDS-PAGE.
The expressed enzyme had a molecular weight and physicochemical and catalytic properties that were almost the same as those of the native enzyme.
Zinc-containing ADHs are structurally related to each other, forming a large family of enzymes, the so-called medium-chain ADH family. Recently, glutathione-dependent FDHs from human and rat livers have been identified as class III ADHs, which are less variable than the traditional liver enzyme of class I (19) and are considered to be predecessors of other classes (5). P. putida FDH is also a zinc-containing metalloenzyme (27) and showed significant homologies to ADHs of various origins, including several bacterial ADHs. There were no significant differences between the homologies with mammalian ADHs of class I and class III (18 versus 17%). Although the overall homology to each ADH compared was relatively low (less than 20%), alignment revealed distant but clear structural relationships between them.
Each class of the mammalian ADH family has been defined on the basis of its functional and physicochemical properties (36) . Class I ADH is cationic and highly sensitive to inhibition by 4-methylpyrazole. Class II ADH is also cationic but is less sensitive to the inhibitor. Class III ADH is the only anionic protein and is insensitive to 4-methylpyrazole. Class I and II ADHs show activity toward ethanol, while class III ADH shows glutathione-dependent FDH activity but is almost inactive toward ethanol. Glutathione-or factor-dependent FDHs from E. coli (13) , Amycolatopsis methanolica (40) , and Rhodococcus erythropolis (7) also behave as ADH class III enzymes, oxidizing and reducing higher aliphatic alcohols and aldehydes, respectively. Functionally, P. putida FDH is similar to class III ADH (glutathione-dependent FDH); it can catalyze the NAD+-dependent oxidation of long-chain alcohols such as n-pentanol but is inactive toward ethanol at high pH values. These bacterial enzymes are also acidic proteins with isoelectric points of between 4 and 7. Strong inhibition by 4-methylpyrazole, however, was observed only for P. putida FDH (Ki = 30 ,uM). The sensitivity to 4-methylpyrazole has been suggested to be related to conditions at position 51 in horse liver E enzyme (9) . All the class I enzymes, which have His-51, are strongly inhibited, while class III enzymes, which have Tyr-51, are almost insensitive. Little is known about other bacterial FDHs with respect to the primary structures, except for the enzyme presented in this paper. So far, the enzyme from P. putida C-83, which has His-51 as in class I ADH, is the only FDH that is strongly inhibited by this inhibitor. Thus, P. putida FDH showed mixed properties in relation to mammalian ADHs of class I and class III.
There are several kinds of enzymes capable of oxidizing formaldehyde. These include aldehyde dehydrogenases (16, 39) , formaldehyde dismutase (21), glutathione-or factordependent FDHs (class III ADHs) (38, 40) , and glutathioneindependent FDH from P. putida. Aldehyde dehydrogenases are nonspecific enzymes; class III ADHs require a helper substrate (glutathione or factor), producing a formyl ester. In this respect, it can be said that the enzyme from P. putida is a genuine FDH.
P. putida FDH is markedly inhibited by PCMB (28) . There are seven cysteine residues in the sequence, and five of them seem identical to those of horse E, whose three-dimensional structure has been crystallographically analyzed. Cys-174 of the horse ADH has been shown to coordinate to the active-site zinc. In the case of P. putida FDH, however, aspartic acid (Asp-169) was aligned at this position (Fig. 6 ). On the basis of computer modeling, it was suggested that the sheep liver sorbitol dehydrogenase had a glutamic acid (Glu-174) as the third active-site zinc ligand (8) . This idea has been supported by a recent site-directed mutagenesis experiment (20) . In E. coli threonine dehydrogenase (3) and Thermoanaerobium brockii ADH (1), an aspartate residue was found in the place of Glu-174 of sheep liver sorbitol dehydrogenase. Nothing is yet known about the zinc coordination of P. putida FDH, but either Cys-166 or Asp-169 might be the third ligand of the active-site zinc. The seventh cysteine residue in P. putida FDH is Cys-257, which seems to be unique to P. putida FDH.
Ogushi et al. indicated that one of the PCMB-reactive sulfhydryl groups is involved in the binding of formaldehyde to the enzyme (28) . This sulfhydryl group probably behaves as an internal glutathione to form a thiohemiacetal as an intermediate in a way proposed for aldehyde dehydrogenase (16). We could not identify the reactive cysteine residue homologous to the active-site cysteine of aldehyde dehydrogenase by sequence comparison. The reaction mechanism of P. putida FDH could be different from that of aldehyde dehydrogenase. The functions of five of seven cysteine residues in P. putida FDH, as mentioned above, are likely to be the same as in horse liver ADH. The roles of Cys-166, Cys-257, and Asp-169 are now being investigated by site-directed mutagenesis to determine the third ligand of the active-site zinc and the reactive cysteine residue.
Mammalian ADHs are usually dimeric proteins. The glutathione-dependent FDH from E. coli was reported to be a homodimer (13) , while P. putida FDH exists as a tetrameric form like other bacterial ADHs (1, 39) . ADHs from yeasts and sheep liver sorbitol dehydrogenase are also known to be tetrameric and lack the region corresponding to the residues 119 to 139 in horse liver ADH (8, 15) . P. putida FDH has this region, but its amino acid sequence is barely homologous to those of dimeric ADHs. The region(s) involved in subunit interaction in P. putida FDH remains to be determined.
In conclusion, glutathione-independent FDH from P. putida belongs to the zinc-containing medium-chain ADH family, although there are extensive variations in the amino acid sequence. The cloned gene and the high-level expression system will be useful to clarify the zinc coordination in P.
putida FDH and the mechanism of glutathione-independent dehydrogenation of formaldehyde by the enzyme.
